Northern Capital Management (Wisconsin)’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-152,300
| Closed | -$192K | – | 164 |
|
|
2017
Q3 | $192K | Buy |
152,300
+46,250
| +44% | +$58.3K | 0.06% | 148 |
|
|
2017
Q2 | $141K | Buy |
106,050
+80,675
| +318% | +$107K | 0.05% | 148 |
|
|
2017
Q1 | $47K | Sell |
25,375
-10,575
| -29% | -$19.6K | 0.02% | 142 |
|
|
2016
Q4 | $186K | Hold |
35,950
| – | – | 0.08% | 135 |
|
|
2016
Q3 | $200K | Buy |
+35,950
| New | +$200K | 0.09% | 132 |
|